DURHAM, N.C. -- In a study of more than 44,000 patients being treated for a possible heart attack, cardiologists at the Duke Clinical Research Institute found that while transfusions were associated ...
Almost 25 years after recombinant human erythropoietin first became available to treat anemia in patients with chronic kidney disease, the optimal use of erythropoiesis-stimulating agents (ESAs) is as ...
The effects of neonatal polycythemia (venous hematocrit ≥ 70 %) and hemodilution on nutritive capillary perfusion were studied by a videophotometric microscopy technique. The capillary blood flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results